Incorporation of mevalonate into squalene, lanosterol and cholesterol by different neonatal chick tissues.
The role of neonatal chick liver and kidneys in the incorporation of mevalonic acid into squalene, lanosterol and cholesterol was studied. Differences between the synthesizing ability of these and other tissues and the influence of the in vivo or in vitro conditions were also examined. In the in vivo experiments, distribution of radioactivity among the nonsaponifiable lipids was not dependent of the doses of mevalonic acid injected. About 80-95% of radioactivity was recovered as cholesterol in liver and brain, whereas in kidneys this percentage was only about 35%. Squalene and lanosterol were formed by kidneys in a high percentage, higher than in liver and other tissues. 12 hr after mevalonate injection, the percentage of cholesterol formed by kidneys increased until more than 50%. In the in vitro experiments carried out in the presence of 0.045-4.0 mM mevalonate, cholesterol was also the main nonsaponifiable identified, but in a lesser percentage than in vivo. In the same conditions, the incorporation of mevalonic acid by kidneys was maximal into squalene. After in vitro incubations for 2 hr, the percentage of cholesterol in kidneys also increased.
D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism; D001711:Biotransformation; D002645:Chickens; D002784:Cholesterol / Q000096:biosynthesis*; D007668:Kidney / Q000378:metabolism; D007810:Lanosterol / Q000096:biosynthesis*; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D008798:Mevalonic Acid / Q000378:metabolism*; D013185:Squalene / Q000096:biosynthesis*
D007810:Lanosterol; D013185:Squalene; D002784:Cholesterol; D008798:Mevalonic Acid